Method for preparing and detecting intermediate and corresponding isomer of afatinib
An enantiomer and afatinib technology, which is applied in the field of content detection of key intermediates and their enantiomers, can solve the problems of different adsorption and desorption capabilities, and large differences in substituents of key intermediates. , to achieve the effect of ensuring precision and accuracy and ensuring optical purity
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2017-02-22
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicines, and in particular relates to a method for detecting the content of a key intermediate for preparing afatinib and its enantiomer. Background technique
[0002] Chiral drugs refer to drugs composed of chiral compounds with pharmacological activity. Because the receptors or targets acted by drug molecules are chiral proteins and nucleic acid macromolecules composed of amino acids, nucleosides, membranes, etc. They have certain requirements on the spatial configuration (chirality) of the drug molecules bound to them. Therefore, the two enantiomers of chiral drugs often have significant differences in pharmacological activity, metabolic process, metabolic rate and toxicity in vivo. Illustrated by a famous incident in the 1960s: racemic thalidomide was a powerful sedative and antiemetic, especially suitable for use in early pregnancy reactions. But it was soon found to be an extremely potent terat...
Examples
Embodiment 1
[0029] Chromatographic conditions: use cellulose-tris(3,5-dimethylphenylcarbamate) as filler (reference column: LuxChiralCellulose-1 (250*4.6mm, 5μm)), column temperature is 25°C, Using n-hexane-isopropanol-acetonitrile (750:200:50) as the mobile phase, the flow rate is 0.9ml per minute, the detection wavelength is 260nm, and the analysis time is 30 minutes.
[0030] Detection method: take N4-(3-chloro-4-fluorophenyl)-7-[[(3S)-tetrahydro-3-furyl]oxy]-4,6-quinazoline diamine compound (formula 2) 10mg, accurately weighed, put in a 20ml measuring bottle, add isopropanol to dissolve and dilute to the mark, shake well, and use it as the test solution. Take an appropriate amount of N4-(3-chloro-4-fluorophenyl)-7-[[(3R)-tetrahydro-3-furyl]oxy]-4,6-quinazolinediamine compound (Formula 3) , add isopropanol to dissolve and quantitatively dilute to make a solution containing 2.5 μg per 1 ml, as the reference solution. Take 10 mg of the compound of formula 2 and 2 mg of the compound of ...
Embodiment 2
[0047] Chromatographic conditions: use cellulose-tris(3,5-dimethylphenylcarbamate) as filler (reference column: LuxChiralCellulose-1 (250*4.6mm, 5μm)), column temperature is 25°C, Using n-hexane-isopropanol-acetonitrile (700:250:50) as the mobile phase, the flow rate is 0.9ml per minute, the detection wavelength is 260nm, and the analysis time is 30 minutes.
[0048] Detection method: take N4-(3-chloro-4-fluorophenyl)-7-[[(3S)-tetrahydro-3-furyl]oxy]-4,6-quinazoline diamine compound (formula 2) 10mg, accurately weighed, put in a 20ml measuring bottle, add isopropanol to dissolve and dilute to the mark, shake well, and use it as the test solution. Take an appropriate amount of N4-(3-chloro-4-fluorophenyl)-7-[[(3R)-tetrahydro-3-furyl]oxy]-4,6-quinazolinediamine compound (Formula 3) , add isopropanol to dissolve and quantitatively dilute to make a solution containing 2.5 μg per 1 ml, as the reference solution. Take 10 mg of the compound of formula 2 and 2 mg of the compound of ...
Embodiment 3
[0061] Chromatographic conditions: use cellulose-tris(3,5-dimethylphenylcarbamate) as filler (reference column: LuxChiral Cellulose-1 (250*4.6mm, 5μm)), column temperature is 25°C , using n-hexane-isopropanol-acetonitrile (800:150:50) as the mobile phase, the flow rate is 0.9ml per minute, the detection wavelength is 260nm, and the analysis time is 30 minutes.
[0062] Detection method: take N4-(3-chloro-4-fluorophenyl)-7-[[(3S)-tetrahydro-3-furyl]oxy]-4,6-quinazoline diamine compound (formula 2) 10mg, accurately weighed, put in a 20ml measuring bottle, add isopropanol to dissolve and dilute to the mark, shake well, and use it as the test solution. Take an appropriate amount of N4-(3-chloro-4-fluorophenyl)-7-[[(3R)-tetrahydro-3-furyl]oxy]-4,6-quinazolinediamine compound (Formula 3) , add isopropanol to dissolve and quantitatively dilute to make a solution containing 2.5 μg per 1 ml, as the reference solution. Take 10 mg of the compound of formula 2 and 2 mg of the compound o...